A
EXAS

Allianz’s Exact Sciences EXAS Stock Holding History

Allianz’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-109
Closed -$4.72K – 412
2025
Q1 		$4.72K Hold
109
– – ﹤0.01% 412
2024
Q4 		$6.13K Sell
109
-421
-79% -$26.2K ﹤0.01% 420
2024
Q3 		$36.1K Hold
530
– – ﹤0.01% 355
2024
Q2 		$22.4K Hold
530
– – ﹤0.01% 421
2024
Q1 		$36.6K Buy
+530
New +$33.5K ﹤0.01% 412

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Allianz's EXAS Position: Q2 2025 in Review

Allianz sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 109 shares — an estimated $4.72K sold.

Allianz first reported a position in EXAS in Q1 2024 and held it in 5 quarters. The position peaked at $36.6K in Q1 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Allianz reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Allianz sold 109 Exact Sciences shares in Q2 2025, an estimated $4.72K.
  • Allianz first reported a position in Exact Sciences in Q1 2024 and held it in 5 quarters.
  • Allianz's Exact Sciences position peaked at $36.6K in Q1 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Allianz's 13F filing for Q2 2025, filed 8 Aug 2025.